Technology

ObsEva

$4.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.55 (+61.51%) Today
-$0.02 (-0.49%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, and ETFs commission-free!

About OBSV

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland. The listed name for OBSV is ObsEva SA Ordinary Shares.

CEO
Brian O'Callaghan
Employees
50
Headquarters
Geneva, Geneve (Geneva)
Founded
2012
Market Cap
187.48M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
16.94M
High Today
$4.39
Low Today
$3.40
Open Price
$3.54
Volume
142.20M
52 Week High
$6.30
52 Week Low
$1.63

Collections

OBSV Earnings

-$0.80
-$0.53
-$0.27
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, Pre-Market

You May Also Like

CFRUY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure